LINC01003

Across TCGA pan-cancer cohorts, LINC01003 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC01003 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC01003 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01003 expression acts as an unfavorable survival marker, although some lineages such as LUAD and OV show a favorable association.

LUAD, OV, and KIRP are the cancer types where LINC01003 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.706	0.421	<.001	90	view →
OV	DFS	Median	III,IV	0.599	0.469	<.001	80	view →
KIRP	DFS	Quartile	All	1.000	0.597	.014	33	view →
KIRC	DFS	Quartile	All	0.869	0.664	.003	28	view →
UCEC	OS	Median	All	0.952	0.901	.008	24	view →
PAAD	OS	Quartile	All	0.642	0.255	.002	22	view →
ACC	DFS	Tertile	III,IV	0.578	0.078	<.001	21	view →
READ	OS	Quartile	All	0.955	0.666	.011	15	view →
BLCA	OS	Quartile	All	0.772	0.596	.008	12	view →
UVM	OS	Median	All	0.780	1.000	.015	12	view →
CHOL	OS	Quartile	All	0.820	0.366	.016	11	view →
SKCM	DFS	Quartile	IV	0.932	0.045	.017	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC01003–LUAD (OS)

Open the LUAD breakdown →